Ur Therapeutics Private Limited - Company Profile

It is a chemicals private limited company based in Bangalore, Karnataka, India, established in 2020.
2020 Bangalore, Karnataka, India Struck Off
Last Updated:
About Ur Therapeutics Private Limited

Ur Therapeutics Private Limited, a struck off private limited company, was established on 10 August 2020 in Bangalore, Karnataka, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24110KA2020PTC137049. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹80.00 K .

Its leadership includes Raja Narendra Reddy Manthakal Reddy Gunthakal (Director), Sathyabalan Murugesan (Director), Jangamreddy Jagan Mohan Reddy (Director). It is based at 3Rd Floor, No.162Ne Nisarga Layout, Bannerghatta Post, Bangalore, Karnataka, 560105.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110KA2020PTC137049

  • Registration Number

    137049

  • Incorporation Date

    10 August 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹80.00 K

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 80.00 K
  • Company Age 5 Year, 9 Months
Company report

Ur Therapeutics Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Ur Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ur Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Raja Narendra Reddy Manthakal Reddy Gunthakal Director 10 Aug 2020 Current
Sathyabalan Murugesan Director 10 Aug 2020 Current
Jangamreddy Jagan Mohan Reddy Director 10 Aug 2020 Current
Shougandh Ghosh Director 10 Aug 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ur Therapeutics.

Enhance accessibility to Ur Therapeutics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ur Therapeutics revenue growth over time
Ur Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ur Therapeutics?

Unlock access to Ur Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ur Therapeutics?

Ur Therapeutics has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ur Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ur Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ur Therapeutics
Recent Activity within the Organization
  • Director Appointment

    Progress on Raja Narendra Reddy Manthakal Reddy Gunthakal was appointed as a Director was appointed as a Director on 10 Aug 2020 & has been associated with this company since 5 years 9 months . was documented.

  • Director Appointment

    The activity Sathyabalan Murugesan was appointed as a Director was appointed as a Director on 10 Aug 2020 & has been associated with this company since 5 years 9 months . was completed.

  • Director Appointment

    Jangamreddy Jagan Mohan Reddy was appointed as a Director was appointed as a Director on 10 Aug 2020 & has been associated with this company since 5 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Shougandh Ghosh was appointed as a Director was appointed as a Director on 10 Aug 2020 & has been associated with this company since 5 years 9 months . was documented.

  • Company Incorporation

    Ur Therapeutics Private Limited was registered on 10 Aug 2020 with Roc Bangalore & aged 5 years 9 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ur Therapeutics Private Limited?

The CIN of Ur Therapeutics Private Limited is U24110KA2020PTC137049.

Where is Ur Therapeutics Private Limited headquartered?

Ur Therapeutics Private Limited is headquartered at 3Rd Floor, No.162Ne Nisarga Layout, Bannerghatta Post, Bangalore, Karnataka, 560105.

When was Ur Therapeutics Private Limited incorporated?

Ur Therapeutics Private Limited was incorporated on 10 August 2020.

Who are the current directors of Ur Therapeutics Private Limited?
What is the primary industry of Ur Therapeutics Private Limited?

The primary industry of Ur Therapeutics Private Limited is Chemicals.

Is Ur Therapeutics Private Limited a listed company?

Ur Therapeutics Private Limited is unlisted.

What is the capital structure of Ur Therapeutics Private Limited?

The authorized capital of Ur Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹80.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available